{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Rising Xylazine Drug Abuse in Humans: A Deep and Lingering High With Wounds, Amputations, and Death

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Recognize the pharmacokinetics of xylazine.
  2. Identify the pharmacodynamics of xylazine.
  3. Choose the adverse effects of xylazine.
  4. Select the interventions for treating xylazine overdose.

Learning Outcomes

Seventy-five percent of participants will demonstrate knowledge of xylazine, a veterinary anesthetic that is now the primary adulterant in fatal fentanyl drug overdoses, by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $17.95

Credits:

  • ANCC 1.5 CH / 1.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH
  • NM - BON 1.5 CH
  • SC - BON 1.5 CH
  • WV - BOERN 1.5 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.

Awarded Advanced Pharmacology Hours













Test Code: CNS0723
Published: Jul/Aug 2023
Expires: 6/6/2025
Required Passing Score: 7/10 (70%)
Authors: Patricia Anne O'Malley, PhD, APRN-CNS
Topics: Xylazine